Meritage Portfolio Management Abb Vie Inc. Transaction History

Meritage Portfolio Management

$1.63 Billion
Q3 2024

A detailed history of Meritage Portfolio Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Meritage Portfolio Management holds 33,535 shares of ABBV stock, worth $6.04 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

33,535

Previous 34,133 1.75%

Holding current value

$6.04 Million

Previous $5.85 Million 13.12%

% of portfolio

0.41%

Previous 0.37%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $97,976 - $119,199	-598 Reduced 1.75%	33,535 $6.62 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $173,210 - $202,270	1,119 Added 3.39%	34,133 $5.85 Million
Q1 2024 Apr 29, 2024	BUY	$159.82 - $182.1 $4.55 Million - $5.18 Million	28,456 Added 624.31%	33,014 $6.01 Million
Q4 2023 Feb 02, 2024	BUY	$137.6 - $154.97 $122,188 - $137,613	888 Added 24.2%	4,558 $706,000
Q3 2023 Oct 30, 2023	SELL	$133.59 - $154.65 $10,152 - $11,753	-76 Reduced 2.03%	3,670 $547,000
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $17,623 - $21,931	-133 Reduced 3.43%	3,746 $505,000
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $2.77 Million - $3.19 Million	-19,157 Reduced 83.16%	3,879 $618,000
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $164,727 - $197,551	1,191 Added 5.45%	23,036 $3.72 Million
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $139,309 - $159,779	1,038 Added 4.99%	21,845 $2.93 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $1.5 Million - $1.91 Million	-10,906 Reduced 34.39%	20,807 $3.19 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $57,147 - $70,903	433 Added 1.38%	31,713 $5.14 Million
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $282,433 - $357,359	-2,629 Reduced 7.75%	31,280 $4.24 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $44,900 - $50,969	-422 Reduced 1.23%	33,909 $3.66 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $11,993 - $13,361	114 Added 0.33%	34,331 $3.87 Million
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $217,899 - $239,880	-2,130 Reduced 5.86%	34,217 $3.7 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $788,882 - $1.07 Million	9,801 Added 36.92%	36,347 $3.9 Million
Q3 2020 Oct 26, 2020	BUY	$85.91 - $100.83 $2.28 Million - $2.68 Million	26,546 New	26,546 $2.33 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Account

Meritage Portfolio Management Abb Vie Inc. Transaction History